benzyl 2,3,4-tri-O-benzyl-D-glucopyranoside | 61277-58-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: benzyl 2,3,4-tri-O-benzyl-D-glucopyranoside
• 英文别名: [(2R,3R,4S,5R)-3,4,5,6-tetrakis(phenylmethoxy)oxan-2-yl]methanol
• CAS: 61277-58-5
• 化学式: C₃₄H₃₆O₆
• 分子量: 540.656
• InChiKey: HYWPIYGUZWWMDH-BKJHVTENSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  40
• 可旋转键数：
  13
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  66.4
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  benzyl 2,3,4-tri-O-benzyl-D-glucopyranoside 在 咪唑 、 三乙胺 、 三氯化磷 作用下， 以 乙腈 为溶剂， 反应 1.75h， 以89%的产率得到6-H-phosphonate-1,2,3,4-tetra-O-benzyl-β-D-glucopyranose
  参考文献：
  名称：

  WO2007/54977

  摘要：

  公开号：
• 作为产物：
  描述：

  benzyl D-glucopyranoside 在 吡啶 、 4-二甲氨基吡啶 、 氢溴酸 、 sodium hydride 、 溶剂黄146 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 19.4h， 生成 benzyl 2,3,4-tri-O-benzyl-D-glucopyranoside
  参考文献：
  名称：

  Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery

  摘要：

  Glycosylated platinum(IV) complexes were synthesized as substrates for GLUTs and OCTs for the first time, and the cytotoxicity and detailed mechanism were determined in vitro and in vivo. Galactoside Pt(IV), glucoside Pt(IV), and mannoside Pt(W) were highly cytotoxic and showed specific cancer-targeting properties in vitro and in vivo. Glycosylated platinum(W) complexes 5, 6, 7, and 8 (IC50 0.24-3.97 mu M) had better antitumor activity of nearly 166-fold higher than the positive controls cisplatin (1a), oxaliplatin (3a), and satraplatin (5a). The presence of a hexadecanoic chain allowed binding with human serum albumin (HSA) for drug delivery, which not only enhanced the stability of the inert platinum(IV) prodrugs but also decreased their reduction by reductants present in human whole blood. Their preferential accumulation in cancer cells compared to noncancerous cells (293T and 3T3 cells) suggested that they were potentially safe for clinical therapeutic use.

  DOI：

  10.1021/acs.jmedchem.7b00433

文献信息

• [EN] PRODRUG BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS<br/>[FR] PROMÉDICAMENT BIPYRIDYLAMINOPYRIDINES EN TANT QU'INHIBITEURS DE SYK
  申请人：MERCK SHARP & DOHME

  公开号：WO2014074421A1

  公开（公告）日：2014-05-15

  The present invention provides compounds of Formula (I), which are prodrugs of trans-4-[(1R)-(6-[4-(difluoromethyl)pyridin-2-yl]amino}-4-methyl-2,3'-bipyridin-6'-yl)-1-hydroxyethyl]cyclohexanecarboxylic acid, a potent inhibitor of Syk. The compounds are useful in the treatment and prevention of diseases mediated by the enzyme, such as asthma, COPD, rheumatoid arthritis and cancer.

  本发明提供了化合物的公式（I），这些化合物是trans-4-[(1R)-(6-[4-(二氟甲基)吡啶-2-基]氨基}-4-甲基-2,3'-联吡啶-6'-基)-1-羟乙基]环己烷羧酸的前药，是Syk的有效抑制剂。这些化合物在治疗和预防由该酶介导的疾病方面非常有用，如哮喘、慢性阻塞性肺病、类风湿性关节炎和癌症。
• Synthesis of Carbohydrate-Templated Amino Acids and Methods of Using Same
  申请人：Schweizer Frank

  公开号：US20080275213A1

  公开（公告）日：2008-11-06

  The present invention generally relates to tetrahydropyranyl-derivatized amino acids, their syntheses and their incorporation into peptides and peptidomimetics. The tetrahydropyran moiety constrains the side chain of an amino acid, thereby providing a molecule that may act as a sugar- or amino acid-mimetic as well as a scaffold for combinatorial synthesis.

  这项发明通常涉及四氢吡喃基衍生的氨基酸，它们的合成以及它们被纳入肽和肽类似物中。四氢吡喃基约束氨基酸的侧链，从而提供一种可能作为糖或氨基酸类似物的分子，同时也作为组合合成的支架。
• [EN] INHIBITORS OF MALARIAL AND PLASMODIUM FALCIPARUM HEXOSE TRANSPORTER AND USES THEREOF<br/>[FR] INHIBITEURS DU TRANSPORTEUR D'HEXOSE DE LA MALARIA ET DE PLASMODIUM FALCIPARUM ET LEURS UTILISATIONS
  申请人：UNIV TSINGHUA

  公开号：WO2021155748A1

  公开（公告）日：2021-08-12

  Provided are molecules capable of binding to binding pockets of Plasmodium falciparum hexose transporter (PfHT) or analogs thereof and complexes comprising the same. Also provided herein are inhibitors of PfHT, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors or the pharmaceutical compositions in the treatment of diseases associated with Plasmodium or PfHT or the killing or inhibiting the growth of Plasmodium. Provided are a set of structure coordinates of such binding pockets and method of using the set of structure coordinates to screen for and design compounds that are capable of binding to PfHT or analogs thereof.

  提供了能够结合到疟原虫己糖转运蛋白（PfHT）或其类似物的结合口袋的分子，以及包含这些分子的复合物。此外，还提供了PfHT的抑制剂，包含这些抑制剂的药物组合物，以及在治疗与疟原虫或PfHT相关的疾病或杀死或抑制疟原虫生长中使用这些抑制剂或药物组合物的方法。提供了这些结合口袋的结构坐标集合，并提供了使用这些结构坐标集合来筛选和设计能够结合到PfHT或其类似物的化合物的方法。
• A highly efficient TEMPO mediated oxidation of sugar primary alcohols into uronic acids using 1-chloro-1,2-benziodoxol-3(1H)-one at room temperature
  作者：Varsha Tiwari、Vishnu Nayak Badavath、Adesh Kumar Singh、Jeyakumar Kandasamy

  DOI：10.1016/j.tetlet.2018.05.021

  日期：2018.6

  Oxidation of various sugar primary alcohols into corresponding uronic acids was demonstrated using 1-chloro-1,2-benziodoxol-3(1H)-one and TEMPO. The reaction proceeds at room temperature in good to excellent yields. Primary alcohols get oxidized selectively over the secondary alcohols under mild reaction conditions.

  使用1-氯-1,2-苯并恶恶唑3（1H）-one和TEMPO证明了各种糖伯醇被氧化为相应的糖醛酸。反应在室温下以良好至极好的收率进行。在温和的反应条件下，伯醇会比仲醇选择性地被氧化。
• New class of alkynyl glycoside analogues as tyrosinase inhibitors
  作者：Natthiya Saehlim、Anan Athipornchai、Uthaiwan Sirion、Rungnapha Saeeng

  DOI：10.1016/j.bmcl.2020.127276

  日期：2020.8

  while 2b exhibited potent activities (IC50 34.3 μM) against L-DOPA higher than kojic acid (IC50 0.11 mM) and arbutin (IC50 13.3 mM). Kinetic studies revealed that compound 2d was a non-competitive inhibitor with the best Ki value of 21 μM and formed an irreversible receptor complex with mushroom tyrosinase. The SARs results showed that the type of alkyne and alkyl groups at position C-6 on sugar and

  通过在糖环的C-1和C-6位置引入各种炔基和烷基，从便宜的可商购糖中设计和合成了一系列新的炔基糖苷类似物。炔基糖苷的抑制能力进行了研究在体外对蘑菇酪氨酸酶为催化升-酪氨酸和升-DOPA作为底物，并与熊果苷和曲酸比较。非末端炔烃化合物2d对1-酪氨酸的酪氨酸酶抑制活性（IC 50 54.0μM）与熊果苷相当（IC 50 1.46 mM），而2b则显示强效活性（IC 50相对于曲酸（IC 50 0.11 mM）和熊果苷（IC 50 13.3 mM），抗L-DOPA的抗药性为34.3μM 。动力学研究表明，化合物2d是一种非竞争性抑制剂，其最佳Ki值为21μM，并与蘑菇酪氨酸酶形成了不可逆的受体复合物。SAR结果表明，糖和立体异构体上C-6位的炔基和烷基类型在确定其抑制活性方面起着重要作用。在这项研究中确定的炔基糖苷的有效活性突出了该支架的重要性，并且这些化合物对于开发新型酪氨酸酶抑制剂非常适度。